June 28, 2024
The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization for the mRNA respiratory syncytial virus (RSV) […]
June 28, 2024
As parents and guardians, you have the important jobs of protecting your children from harm and of teaching them to make good choices as they grow […]
June 28, 2024
At its June 27 meeting, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorizations for four […]
June 28, 2024
XOLREMDI (mavorixafor) zol-REM-deeX4 Pharmaceuticals, Inc.Original Approval date: April 26, 2024 DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? XOLREMDI is a prescription drug that increases the […]
June 28, 2024
EXBLIFEP (cefepime and enmetazobactam)EX-BLEE-FEPAllecra Therapeutics SAS Original Approval date: February 22, 2024 DRUG TRIALS SNAPSHOT SUMMARY: What is the drug for? EXBLIFEP is a combination of cefepime […]
June 28, 2024
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given negative opinions for two drugs intended to treat amyotrophic lateral sclerosis (ALS) […]
June 28, 2024
On this page: American medicine cabinets contain a growing choice of nonprescription, over-the-counter (OTC) medicines to treat an expanding range of ailments. OTC medicines often do […]
June 28, 2024
At its June 2024 meeting, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) gave Winrevair (sotatercept; Merck Sharp & Dohme) a positive […]
June 28, 2024
The European Medicines Agency has recommended the first emergency treatment for allergic reactions to be administered as a nasal spray, not as an injection. Eurneffy (epinephrine) […]